ChemoCentryx
Patents, Design & Utilities
Last updated:
List of all ChemoCentryx patents 128 in total
| Status | Patent |
|---|---|
Application | Utility: CXCR7 ANTAGONISTS Filling date: 8 Sep 2025 Issue date: 26 Mar 2020 |
Grant | Utility: Aza-aryl 1H-pyrazol-1-yl benzene sulfonamides Filling date: 8 Sep 2025 Issue date: 24 Mar 2020 |
Grant | Utility: Methods of treating pancreatic cancer Filling date: 8 Sep 2025 Issue date: 10 Mar 2020 |
Application | Utility: COMBINATION THERAPY USING C-C CHEMOKINE RECEPTOR 4 (CCR4) ANTAGONISTS AND ONE OR MORE IMMUNE CHECKPOINT INHIBITORS Filling date: 8 Sep 2025 Issue date: 5 Mar 2020 |
Grant | Utility: Indane-amines as PD-L1 antagonists Filling date: 8 Sep 2025 Issue date: 25 Feb 2020 |
Grant | Utility: Reducing tumor burden by administering CCR1 antagonists in combination with PD-1 inhibitors or PD-L1 inhibitors Filling date: 8 Sep 2025 Issue date: 25 Feb 2020 |
Application | Utility: MACROCYCLIC IMMUNOMODULATORS Filling date: 8 Sep 2025 Issue date: 20 Feb 2020 |
Grant | Utility: 6-5 fused rings as C5a inhibitors Filling date: 8 Sep 2025 Issue date: 18 Feb 2020 |
Application | Utility: MODULATORS OF CHEMOKINE RECEPTORS Filling date: 8 Sep 2025 Issue date: 6 Feb 2020 |
Grant | Utility: Processes and intermediates in the preparation of C5aR antagonists Filling date: 8 Sep 2025 Issue date: 14 Jan 2020 |
Grant | Utility: Heteroaryl sulfonamides and CCR2/CCR9 Filling date: 8 Sep 2025 Issue date: 14 Jan 2020 |
Grant | Utility: Compositions and methods for treating inflammatory bowel disease using a combination therapy of small molecule inhibitors of C-C chemokine receptor 9 (CCR9) and anti-.alpha.4.beta.7 integrin blocking antibodies Filling date: 8 Sep 2025 Issue date: 14 Jan 2020 |
Application | Utility: DOSING AND EFFECT OF C5a ANTAGONIST WITH ANCA-ASSOCIATED VASCULITIS Filling date: 8 Sep 2025 Issue date: 12 Dec 2019 |
Grant | Utility: Soluble C5aR antagonists Filling date: 8 Sep 2025 Issue date: 26 Nov 2019 |
Application | Utility: METHODS OF TREATING PANCREATIC CANCER Filling date: 8 Sep 2025 Issue date: 21 Nov 2019 |
Grant | Utility: Substituted tetrahydropyrans as CCR2 modulators Filling date: 8 Sep 2025 Issue date: 5 Nov 2019 |
Application | Utility: PRODRUGS OF FUSED-BICYCLIC C5aR ANTAGONISTS Filling date: 8 Sep 2025 Issue date: 3 Oct 2019 |
Grant | Utility: 2-oxindole compounds Filling date: 8 Sep 2025 Issue date: 24 Sep 2019 |
Application | Utility: INDANE-AMINES AS PD-L1 ANTAGONISTS Filling date: 8 Sep 2025 Issue date: 19 Sep 2019 |
Application | Utility: PROCESSES AND INTERMEDIATES IN THE PREPARATION OF C5aR ANTAGONISTS Filling date: 8 Sep 2025 Issue date: 12 Sep 2019 |
Application | Utility: COMBINATION THERAPY USING A CHEMOKINE RECEPTOR 2 (CCR2) ANTAGONIST AND A PD-1/PD-L1 INHIBITOR Filling date: 8 Sep 2025 Issue date: 12 Sep 2019 |
Grant | Utility: Substituted anilines as CCR(4) antagonists Filling date: 8 Sep 2025 Issue date: 10 Sep 2019 |
Application | Utility: SOLUBLE C5aR ANTAGONISTS Filling date: 8 Sep 2025 Issue date: 5 Sep 2019 |
Application | Utility: METHODS OF TREATING SOLID TUMORS WITH CCR2 ANTAGONISTS Filling date: 8 Sep 2025 Issue date: 5 Sep 2019 |
Grant | Utility: Methods of treating pancreatic cancer Filling date: 8 Sep 2025 Issue date: 3 Sep 2019 |
Grant | Utility: Macrocyclic immunomodulators Filling date: 8 Sep 2025 Issue date: 27 Aug 2019 |
Grant | Utility: Inhibitors of CXCR2 Filling date: 8 Sep 2025 Issue date: 6 Aug 2019 |
Grant | Utility: Aryl sulfonamides Filling date: 8 Sep 2025 Issue date: 30 Jul 2019 |
Showing 100 to 128 of 128 patents.